Asia Pacific Sterility Testing Market Research Report-Forecast till 2027

Asia Pacific Sterility Testing Market Research Report– By Product (Instrument, Kits), Tests (Membrane Filtration Sterility, Direct Incubation Sterility), Application (Pharmaceutical & Biological, Medical Devices), End User - Forecast till 2027

ID: MRFR/LS/0178-HCR | February 2021 | Region: Global | 60 pages

Asia Pacific Sterility Testing Market Scenario


Sterility testing plays an important role in the healthcare sector. It ensures the purity and safety of the product or a substance. This is a vital regulatory requirement for both pharmaceutical and medical device companies when bringing a product to market or assessing the post-launch safety of a product or device. It is an essential part of every sterilization validation and is an extremely difficult process that must be designed and executed for eliminating false positive results, which, are generally due to laboratory contamination from the testing environment or technician error.


The major driving factor for the growth of the market are increasing manufactures of the medical devices & products, increasing prevalence of many infectious diseases, and increasing in the Research and development projects in life sciences. Increasing number of diseases has intensified the research activity which has significantly driven the Asia Pacific sterility testing market. Currently, about 27 million deaths occur each year in South and East Asia, 7 million among those are under 30 years of age, and 10 million fall in the middle-aged group. Beside this, huge population base in this region, rising outsourcing in the pharmaceutical sector to the emerging nations such as India and China, and rapid development in economy has provided a support for the growth of the Asia Pacific sterility testing market. Furthermore, growth of pharmaceutical industries, technological advances, increasing support provided by government and, the increasing R&D investments have fuelled the Asia Pacific sterility testing market growth in this region. However, a cumbersome approval process and strict regulatory rules are few factors responsible for restraining the Asia Pacific sterility testing market growth.


Sterility also relies on procedural measures that effectively prevent contamination of biological materials, such as clean room technology and other Good Manufacturing Practices.


The Asia Pacific sterility testing market is expected to grow at a CAGR of 10.2% during 2017-2023 


Intended Audience



  • Product manufacturers of sterility product

  • Sterility Testing Product Distributors

  • Government and private research companies

  • Research and Development (R&D) Companies

  • Hospitals and Laboratories

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities 


Figure: Asia pacific sterility testing market, by products 2016 (%) Asia Pacific Sterility Testing Market--


               Sources: Annual reports, Press release, White paper, Company presentation


Segmentations

Asia Pacific sterility testing market is segmented on the basis of products, types of test, application, and end users.


On basis of type of product the Asia Pacific sterility testing market is segmented into instrument, reagent & services, kits and others.


On the basis of type of tests, the Asia Pacific sterility testing market is segmented into membrane filtration sterility testing, direct incubation sterility testing, direct transfer and others.


On Application, the Asia Pacific sterility testing market is segmented into pharmaceutical & biological manufacturing, medical devices manufacturing, and others.


On the basis of end user, they are segmented into pharmaceuticals, hospital & laboratories and other.


Regional Analysis

On the regional basis Asia Pacific is segmented into Japan, India, China, the republic of Korea, Australia and the Rest of Asia Pacific.


Japan holds a major shares of the market owing to increase in number of approval of new drugs and high spending on quality control.


China and India has a growing market due to huge population base, increasing demand for the better quality products, rapidly changing economy, increasing healthcare expenditure, and increasing number of pharmaceutical & biotechnological companies.


Reports suggest that China and Southeast Asia are poised to join the ranks of the high-growth Asian economies such as Korea and Taiwan


Rest of Asia Pacific holds the least share in the market.


Increasing number of healthcare organizations like hospital, private research institute has led to increase in the market in India.


Key Players

Some of the major player in the Asia Pacific sterility testing market are Avance Biosciences (U.S.), Boston Scientific Corporation (U.S.), Paragon Bioservices, Inc (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Avista Pharma Solutions (U.S.), and DYNALABS LLC. (U.S.)



Table of Contents

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Asia Pacific Sterility Testing Market, by Type

6.1 Introduction

6.2 Instrument

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Reagent & Services

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Kits

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Others

7. Asia Pacific Sterility Testing Market, by Type of Tests

7.1 Introduction

7.2 Membrane Filtration Sterility Testing

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Direct Incubation Sterility Testing

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Direct Transfer

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Others

8. Asia Pacific Sterility Testing Market, by Application

8.1 Introduction

8.2 Pharmaceutical & Biological Manufacturing

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Medical Devices Manufacturing

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Others

9. Asia Pacific Sterility Testing Market, by End user

9.1 Introduction

9.2 Pharmaceuticals

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Hospital & Laboratories

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Others

10. Asia Pacific Sterility Testing Market, by Region

10.1 Introduction

10.2 Asia Pacific

10.2.1 Japan

10.2.2 China

10.2.3 India

10.2.4 Republic of Korea

10.2.5 Australia

10.2.6 Rest of Asia Pacific

11 Competitive Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Boston Scientific Corporation

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Charles River Laboratories International, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Avance Biosciences

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Paragon Bioservices, Inc

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Thermo Fisher Scientific, Inc.

12.5.1 Company Overview

12.5.2 Product/Business Segment Overview

12.5.3 Financial Overview

12.5.4 Key Development

12.5.5 SWOT Analysis

12.6 Avista Pharma Solutions

12.6.1 Company Overview

12.6.2 Product/Business Segment Overview

12.6.3 Financial Overview

12.6.4 Key Development

12.6.5 SWOT Analysis

12.7 DYNALABS LLC.

12.7.1 Company Overview

12.7.2 Product/Business Segment Overview

12.7.3 Financial Overview

12.7.4 Key Development

12.7.5 SWOT Analysis

12.8 Merck KGaA

12.8.1 Company Overview

12.8.2 Product/Business Segment Overview

12.8.3 Financial Overview

12.8.4 Key Development

12.8.5 SWOT Analysis

12.9 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Sterility testing Industry Synopsis, 2020-2027

Table 2 Asia Pacific Sterility Testing Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Asia Pacific Sterility Testing Market by Region, 2020-2027, (USD Million)

Table 4 Asia Pacific Sterility Testing Market by Types, 2020-2027, (USD Million)

Table 5 Asia Pacific Sterility Testing Market by Tests, 2020-2027, (USD Million)

Table 6 Asia Pacific Sterility Testing Market by Application, 2020-2027, (USD Million)

Table 7 Asia Pacific Sterility Testing Market by End Users, 2020-2027, (USD Million)

Table 8 Japan Sterility Testing Market by Types, 2020-2027, (USD Million)

Table 9 Japan Sterility Testing Market by Tests, 2020-2027, (USD Million)

Table 10 Japan Sterility Testing Market by Application, 2020-2027, (USD Million)

Table 11 Japan Sterility Testing Market by End Users, 2020-2027, (USD Million)

Table 12 China Sterility Testing Market by Types, 2020-2027, (USD Million)

Table 13 China Sterility Testing Market by Tests, 2020-2027, (USD Million)

Table 14 China Sterility Testing Market by Application, 2020-2027, (USD Million)

Table 15 China Sterility Testing Market by End Users, 2020-2027, (USD Million)

Table 16 India Sterility Testing Market by Types, 2020-2027, (USD Million)

Table 17 India Sterility Testing Market by Tests, 2020-2027, (USD Million)

Table 18 India Sterility Testing Market by Application, 2020-2027, (USD Million)

Table 19 India Sterility Testing Market by End Users, 2020-2027, (USD Million)

Table 20 Republic of Korea Sterility Testing Market by Types, 2020-2027, (USD Million)

Table 21 Republic of Korea Sterility Testing Market by Tests, 2020-2027, (USD Million)

Table 22 Republic of Korea Sterility Testing Market by Application, 2020-2027, (USD Million)

Table 23 Republic of Korea Sterility Testing Market by End Users, 2020-2027, (USD Million)

Table 24 Rest of Asia Pacific Sterility Testing Market by Types, 2020-2027, (USD Million)

Table 25 Rest of Asia Pacific Sterility Testing Market by Tests, 2020-2027, (USD Million)

Table 26 Rest of Asia Pacific Sterility Testing Market by Application, 2020-2027, (USD Million)

Table 27 Rest of Asia Pacific Sterility Testing Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Asia Pacific Sterility Testing Market

Figure 3 Segmentation Market Dynamics for Sterility Testing Market

Figure 4 Asia Pacific Sterility Testing Market Share, by Types 2020

Figure 5 Asia Pacific Sterility Testing Market Share, by Tests 2020

Figure 6 Asia Pacific Sterility Testing Market Share, by Applications, 2020

Figure 7 Asia Pacific Sterility Testing Market Share, by End Users, 2020

Figure 8 Asia Pacific Sterility Testing Market Share, by Region, 2020

Figure 9 Asia Pacific Sterility Testing Market: Company Share Analysis, 2020 (%)

Figure 10 Boston Scientific Corporation: Key Financials

Figure 11 Boston Scientific Corporation: Segmental Revenue

Figure 12 Boston Scientific Corporation: Geographical Revenue

Figure 13 Charles River Laboratories International, Inc.: Key Financials

Figure 14 Charles River Laboratories International, Inc.: Segmental Revenue

Figure 15 Charles River Laboratories International, Inc.: Geographical Revenue

Figure 16 Avance Biosciences: Key Financials

Figure 17 Avance Biosciences: Segmental Revenue

Figure 18 Avance Biosciences: Geographical Revenue

Figure 19 Paragon Bioservices, Inc: Key Financials

Figure 20 Paragon Bioservices, Inc: Segmental Revenue

Figure 21 Paragon Bioservices, Inc: Geographical Revenue

Figure 22 Thermo Fisher Scientific, Inc.: Key Financials

Figure 23 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 24 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 25 Avista Pharma Solutions: Key Financials

Figure 26 Avista Pharma Solutions: Segmental Revenue

Figure 27 Avista Pharma Solutions: Geographical Revenue

Figure 28 Dynalabs LLC: Key Financials

Figure 29 Dynalabs LLC: Segmental Revenue

Figure 30 Dynalabs LLC: Geographical Revenue

Figure 31 Merck KGaA: Key Financials

Figure 32 Merck KGaA: Segmental Revenue

Figure 33 Merck KGaA: Geographical Revenue